(421 days)
No
The device description focuses on mechanical function and custom fitting, with no mention of AI/ML terms or data processing.
Yes
The device is intended to alleviate snoring and mild to moderate obstructive sleep apnea, which are medical conditions, thus making it a therapeutic device.
No
Explanation: The device is described as an intra-oral device used for treating snoring and mild to moderate obstructive sleep apnea by repositioning the mandible, not for diagnosing these conditions. Its purpose is therapeutic, not diagnostic.
No
The device description clearly describes a physical, intra-oral device consisting of custom-fitted trays and an adjustment mechanism, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Airwayease MAS is an intra-oral device that physically repositions the jaw to improve airflow. It does not analyze biological samples.
- Intended Use: The intended use is to reduce snoring and sleep apnea by physically altering the airway, not by diagnosing or monitoring a condition through sample analysis.
The device is a medical device, specifically a mandibular advancement splint, but it falls under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
The Airwayease MAS is intended to reduce or alleviate night time snoring and mild to moderate obstructive sleep apnoea.
Product codes (comma separated list FDA assigned to the subject device)
LRK
Device Description
The Airwayease MAS is an intra-oral device used for treating Snoring and mild to moderate Obstructive Sleep Apnoea. It consists of two custom fitted trays which fit over the upper and lower teeth and engage by means of interchangeable lugs. The device functions as a mandibular repositioner, which acts to increase the patient's pharyngeal space during sleep and improves their ability to exchange air during sleep.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult patients 18 years or older who have a problem with snoring or obstructive sleep apnoea.
Intended User / Care Setting
The device is initially fitted under the supervision of a licensed practitioner (dentist or physician) and is subsequently used in either a home environment or in a sleep laboratory.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.5570 Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea.
(a)
Identification. Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.(b)
Classification. Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”
0
510(K) SUMMARY
This summary of 510(K) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR §807.92.
Submitter Information:
APR 1 & 2010
Orthoplant Dental Lab
Suite A31-A, Level 3,
24-32 Lexington Drive,
Bella Vista NSW, 2153, Australia
Ph; 612 80904358
Mb; 612 0408169182
Fax; 612 88243516
Date Summary Prepared: 21st February 2010
Contact Person: Christopher Kelly
Device Name: Trade Name(s): Airwayease MAS Classification Name: Device, Anti-snoring (21CFR872.5570) Panel: Dental Product Code: LRK
Predicate Device Information:
| Device Name | Manufacturer | 510(k) Reference |
|---|---|---|
| SomnoMed MAS Flex "S" | SomnoMed Inc | K073004 |
Device Description:
The Airwayease MAS is an intra-oral device used for treating Snoring and mild to moderate Obstructive Sleep Apnoea. It consists of two custom fitted trays which fit over the upper and lower teeth and engage by means of interchangeable lugs. The device functions as a mandibular repositioner, which acts to increase the patient's pharyngeal space during sleep and improves their ability to exchange air during sleep.
1
The device is custom made for each patient and has the adjustment mechanism enabling the amount of mandibular advancement as well as vertical change to be set by the dentist or physician at the time of fitting the device.
The ranges of mandibular advancement are up to 7mm from the starting point of the construction bite supplied by the dentist, as well as 7mm of vertical opening from the starting point of the construction bite supplied by the dentist.
Lateral movement of the jaw is limited by the device and as such this device is contra-indicated for those patients requiring the ability to move their lower jaw in a lateral direction whilst wearing the device.
Vertical opening for the Airwayease MAS is unrestricted except by that of the patient's individual physiology.
Intended use - The Airwayease MAS is intended to reduce or alleviate night time snoring and mild to moderate obstructive sleep apnoea.
Target population - Adult patients 18 years or older who have a problem with snoring or obstructive sleep apnoea.
Environment of Use - The device is initially fitted under the supervision of a licensed practitioner (dentist or physician) and is subsequently used in either a home environment or in a sleep laboratory.
Materials - The material composition of the Airwayease MAS is identical to the Ivocap Elastomer cleared in K896130. No colorants or additives have been added to the originally cleared Ivocap Elastomer. NO evidence of biocompatibility issues with previous use of the same material in other dental appliances is known. The lugs in the Airwayease MAS which are made from DuPont Nylon and is identical to that used in the predicate appliance EMA (K971794), no evidence is known that biocompatibility is an issue.
2
Comparison to Predicate Device:
The Airwayease MAS is substantially equivalent to the SomnoMed MAS Flex "S" with the soft lining material (SMH Flex "S") for retention. The two types of retention are the same and the Airwayease MAS is entirely made out of- "Ivocap Elastomer" m which is technologically advanced to grip around the tooth creating a good retention which is designed for patient comfort, this negates the need for metal retention such as ball clasps. The Ivocap Elastomer also allows the interchangeable adjustment components to be removed and exchanged in the event of a desired change in position for the lower jaw. In the event that the components are exchanged they might simply be secured into the base with acrylic, making them secure. This difference does not have significant effect on the safety or effectiveness of the Airwayease MAS.
| Comparison Data of Predicate devices | ||||
|---|---|---|---|---|
| Attributes | Somnomed | |||
| MAS flex | ||||
| K0703004 | OASYS | |||
| K030440 | TAP III | |||
| K062951 | Airwayease | |||
| MAS | ||||
| Indications for use | ||||
| Treatment of snoring in Adults | Yes | Yes | Yes | Yes |
| Treatment of mild to moderate sleep apnoea | Yes | Yes | Yes | Yes |
| Contra-Indications for use | ||||
| Intended to be used with patients who wear full | ||||
| or partial dentures. | NO | NO | NO | NO |
| intended for lateral bruxers | NO | NO | NO | NO |
| Use | ||||
| Intra Oral device for overnight use | Yes | Yes | Yes | Yes |
| Single patient multi use | Yes | Yes | Yes | Yes |
| Use at home or in sleep lab | Yes | Yes | Yes | Yes |
| Prescription device | Yes | Yes | Yes | Yes |
| Action | ||||
| Works by mandibular advancement and | ||||
| vertical repositioning | NO | NO | NO | Yes |
| Design | ||||
| Custom fit for each patient | Yes | Yes | Yes | Yes |
| Rigid separate upper and lower tray pieces | Yes | Yes | Yes | No |
| Flexible separate upper and lower tray pieces | No | No | No | Yes |
| Can be adjusted or refit | Yes | Yes | Yes | Yes |
| Lower jaw adjustment using a supplied | ||||
| adjustment key or interchangeable part | Yes | Yes | Yes | Yes |
| Permits patient to breathe through mouth | Yes | Yes | Yes | Yes |
| Materials | ||||
| Trays constructed from hard acrylic and ball | ||||
| clasps | No | yes | No | No |
| Trays made from a soft lined self cure | ||||
| material | Yes | No | Yes | No |
| Trays made from thermo plastic material | No | No | Yes | No |
3
The difference between the intended device Airwayease MAS and the predicate devices are the materials. All of the predicates act as mandibular advancement splints for the treatment of Snoring and mild to moderate Obstructive Sleep Apnoea. This difference does not have significant effect on the safety or effectiveness of the Airwayease MAS.
Justification for the use of the Ivocap Elastomer in the fabrication of the Airwayease MAS is to be able to have a secure well fitting appliance that is able to withstand the destructive forces of the mouth. The material provides comfort in the flexibility of the material when being worn at night and this same flexibility reduces the occurrence of breakages suffered by other rigid materials used in other MAS devices.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features the department's name arranged in a circular fashion around the left side of the image. To the right of the text is a symbol consisting of three stylized, overlapping shapes that resemble birds in flight or abstract human figures.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
APR 1 8 2010
Mr. Christopher Kelly Owner Orthoplant Dental Lab 24-32 Lexington Drive, Suite A31-A, Level 3 Bella Vista, New South Wales AUSTRALIA 2153
Re: K090436
Trade/Device Name: Airwayease MAS
Regulation Number: 21 CFR 872.5570
Regulation Name: Intraoral Devices for Snoring and Intraoral Devices for Snoring and Obstructive Sleep Apnea.
Regulatory Class: II Product Code: LRK Dated: February 21, 2010 Received: March 30, 2010
Dear Mr. Christopher Kelly:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2- Mr. Christopher Kelly
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Th for
Anthony D. Watson, BS, MS, MBA Director
Division of Anesthesiology, General Hospital, Infection Control. and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): K090436
Device Name: Airwayease MAS
Indications for Use:
The Airwayease MAS is intended to reduce or alleviate night time snoring and mild to moderate obstructive sleep apnea (OSA).
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
R.Betzold for Dr. Susan Runner
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K690436